Hydrogenology
Source-linked study record

Effectiveness and safety of hydrogen inhalation therapy as an additional treatment for hypertension in real-world practice: a retrospective, observational study in China

Ji H, Sun H, Zhang Y, Zhao Z, Gao X, Wang C, Yang Y, Zhang X, Gao J, Man D, Yang Q, Yang Y, Yue C, Chen C, Ding X, Ni T. · Frontiers in cardiovascular medicine. 2024;11:1391282.

HumanInhaled H₂Published 2024Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Human

Population or model

Human participants studied for cardiovascular and circulatory health. See eligibility criteria in the linked full text.

Intervention and dose

Full text reports inhaled H₂-containing gas. Detected intervention quantities or schedules: 2.0 L/min, 140 mm, 90 mm. · H₂-related quantities reported in the intervention passages: 2.0 L/min, 140 mm, 90 mm. Values are not combined across different experimental arms.

Duration

2.0 L/min

Reported result

Article-reported result excerpt (24 words maximum): “The SBP levels decreased in HI group (−5.93 mm Hg; 95% CI, −7.30 to −4.57) and control group (−1.31 mm Hg; 95% CI, −2.61…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Main limitation

Human evidence; design, sample size and comparator limit interpretation. Funding or grant information is reported in the full article. The article declares no conflicts of interest.

Evidence and classification

What kind of evidence is this?

Evidence type

Human

Reported design

Prospective human study

Research topic

Cardiovascular and circulatory health

Administration form

Inhaled H₂

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Human participants studied for cardiovascular and circulatory health. See eligibility criteria in the linked full text.

Sample

Human study; the full text reports 126 patients, with group/assay counts including n=1, n=305.

Duration

2.0 L/min

Intervention

Full text reports inhaled H₂-containing gas. Detected intervention quantities or schedules: 2.0 L/min, 140 mm, 90 mm.

Hydrogen form

Inhaled molecular H₂; not classified as Brown’s gas without an H₂/O₂ composition.

Dose or H₂ specification

H₂-related quantities reported in the intervention passages: 2.0 L/min, 140 mm, 90 mm. Values are not combined across different experimental arms.

H₂ flow

Not reported in the full article — an absolute H₂ flow in mL/min could not be verified.

O₂ delivered with H₂

O₂ concentration and absolute O₂ flow were not both reported in the full article; no value is inferred.

Comparator

Placebo or matched control reported in the full article.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

clinical symptoms or functional scores, tumor growth or cancer markers, oxidative-stress and antioxidant markers, apoptosis or cell injury, histology or tissue damage, metabolic laboratory measures

Reported result

Article-reported result excerpt (24 words maximum): “The SBP levels decreased in HI group (−5.93 mm Hg; 95% CI, −7.30 to −4.57) and control group (−1.31 mm Hg; 95% CI, −2.61…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Extraction completeness

The complete machine-readable article was checked for source identity, methods, intervention quantities, results, tables, funding and conflict declarations. This public record is based on the full article.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Human evidence; design, sample size and comparator limit interpretation. Funding or grant information is reported in the full article. The article declares no conflicts of interest.

Applies directly to

Applies only to the population and protocol reported in this cardiovascular and circulatory health article.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 39600611 · DOI: 10.3389/fcvm.2024.1391282

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed/PMC full article; source identity, intervention data and declarations re-audited 25 August 2026.

Last reviewed

25 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.